Addtime:2023-08-28 Hit: 1079
Product name | CDE registration number | Pharmacopoeia specification compliance |
PEG 300(For Injection) | F20190001874(A) | USP/EP/ChP |
PEG 400(For Injection) | F20190001859(A) | USP/EP/JP/ChP |
CAS number: 25322-68-3
Storage: In an airtight container.
Properties and Benefits
l Using precise polymerization technology, good process control ensures stable polymerization degree of the product.
l Advanced refining technologies can guarantee excellent batch-to-batch repeatability.
l Low impurities content, strictly control on potential mutagenic or toxic impurities such as ethylene glycol, diethylene glycol, and triethylene glycol in the product to ensure the safety of parenteral formulations.
l Low peroxide value helps to improve the stability of the preparation.
l Bacterial endotoxins and micro-organisms are strictly controlled, meet the requirements of parenteral dosage forms.
Applications
l Widely used as a solvent for injections and ophthalmic preparations.
l As suspending agent, thickener and plasticizer in liquid and semi-solid preparations to maintain the physical properties and improve the stability of the preparations.